共 53 条
[1]
Schäufele M(2013)Prävalenz von Demenzen und ärztliche Versorgung in deutschen Pflegeheimen: eine bundesweite repräsentative Studie Psychiatr Prax 40 200-206
[2]
Holt S(2010)Potenziell inadäquate Medikation für ältere Menschen: Die PRISCUS-Liste Dtsch Arztebl Int 107 543-551
[3]
Schmiedl S(2009)Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease J Neurol Neurosurg Psychiatr 80 600f-324
[4]
Thürmann PA(2004)Memantine treatment in patients with moderate to severe Alzheimer disease already receiving Donepezil: a randomized controlled trial J Am Med Assoc 291 317-154
[5]
Lopez OL(2006)Economic considerations in the management of Alzheimer’s disease Clin Interv Aging 1 143-234
[6]
Tariot PN(2003)Behavioural and psychological symptoms of dementia: a seven-tiered model of service delivery Med J Aust 178 231-2341
[7]
Zhu CW(2005)Risk of death in elderly users of conventional vs. atypical antipsychotic medications N Engl J Med 353 2335-528
[8]
Brodaty H(2016)Ginkgo Biloba for mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials Curr Top Med Chem 16 520-2077
[9]
Wang PS(2014)Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials Clin Interv Aging 9 2065-109
[10]
Yang G(2015)Pharmacological treatment of neuropsychiatric symptoms in Alzheimer’s disease: a systematic review and meta-analysis J Neurol Neurosurg Psychiatr 86 101-263